#Pfizer
"As seen in real world data released from the Israel Ministry of Health, vaccine efficacy in preventing both infection and symptomatic disease has declined six months post-vaccination, although efficacy in preventing serious illnesses remains high" cnn.com/2021/07/08/hea…
"Pfizer and BioNTech believe that a third dose may be beneficial within 6 to 12 months following the second dose to maintain highest levels of protection."
"But in an unusual move, two top federal agencies said Americans don't need boosters yet and said it was not up to companies alone to decide when they might be needed."
"Hours after Pfizer issued its statement, the FDA and Centers for Disease and Control issued a joint statement saying Americans do not need booster shots yet.
"Americans who have been fully vaccinated do not need a booster shot at this time," they said."
"Israel's health ministry said in a statement earlier this week that it had seen efficacy of Pfizer's vaccine drop from more than 90% to about 64% as the B.1.617.2 or Delta variant spread."
"Pfizer said research showed booster doses of its vaccine, developed with BioNTech, produced levels of neutralizing antibodies that are five to 10 times higher than what's produced after two doses."
• • •
Missing some Tweet in this thread? You can try to
force a refresh
RIVM (2019): "onder gentherapie wordt verstaan klinisch onderzoek in mensen waarbij handelingen uitgevoerd worden met een genetisch gemodificeerd organisme (GMO)."
"The absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs:
1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines."
"There are many lessons to learn from the way studies are conducted and results are presented. With the use of only RRRs, and omitting ARRs, reporting bias is introduced, which affects the interpretation of vaccine efficacy."
"De avondklok heeft vermoedelijk weinig tot geen effect gehad op het verloop van de corona-epidemie in Nederland. Dat is de voorlopige conclusie van Sake de Vlas, hoogleraar infectieziektemodellering aan de Erasmus Universiteit in Rotterdam."
"Hoogleraar De Vlas wijst erop dat de critici van Kuipers zich baseren op mededelingen van het RIVM dat kort na de invoering van de avondklok twee derde van alle besmettingen in Nederland de Britse variant betrof."